NCT03774693

Brief Summary

Septorhinoplasty is a cosmetic surgery that many people are choosing to undergo. It can be done under general anesthesia, twilight anesthesia or regional anesthesia. Controlled hypotensive anesthesia is required to minimize bruising, swelling, and bleeding that reduces visibility in the operative field and hence satisfactory surgical outcome. The goal of our study to prove that regional block of the nose provides efficient hypotensive anesthesia

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 28, 2018

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

December 11, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 13, 2018

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2019

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2019

Completed
Last Updated

December 17, 2018

Status Verified

December 1, 2018

Enrollment Period

2 months

First QC Date

December 11, 2018

Last Update Submit

December 14, 2018

Conditions

Outcome Measures

Primary Outcomes (2)

  • Hypotensive anesthesia

    Measurement of Mean arterial blood pressure

    Intraoperative

  • Requirements of Fentanyl

    Assessment of intraoperative fentanyl doses of \[Fentanyl boluses of 0.5 mcg.Kg-1 will be given to maintain mean arterial pressure (MAP) between 55-65 mmHg with a maximum dose of 3 mcg.Kg-1\]

    Intraoperative

Secondary Outcomes (1)

  • Average category scale (ACS)

    Intraoperative

Study Arms (2)

GS [General anesthesia]

ACTIVE COMPARATOR

Patients will receive general anesthesia with Fentanyl boluses of 0.5 mcg.Kg-1 given to maintain MAP between 55-65 mmHg with a maximum dose of 3 mcg.Kg-1.

Other: General anesthesia with fentanyl boluses

GR [General anesthesia + regional block]

ACTIVE COMPARATOR

Patients will receive general anesthesia with Fentanyl boluses of 0.5 mcg.Kg-1 given to maintain MAP between 55-65 mmHg with a maximum dose of 3 mcg.Kg-1. Also patients will receive trans-oral bilateral sphenopalatine ganglion block and trans-oral bilateral infraorbital nerve block. Fentanyl boluses of 0.5 mcg.Kg-1 will be given when needed to maintain MAP between 55-65 mmHg with a maximum dose of 3 mcg.Kg-1.

Other: General anesthesia with fentanyl bolusesProcedure: Regional block

Interventions

Patients will receive general anesthesia with Fentanyl boluses of 0.5 mcg.Kg-1 given to maintain MAP between 55-65 mmHg with a maximum dose of 3 mcg.Kg-1

GR [General anesthesia + regional block]GS [General anesthesia]

Patients will receive trans-oral bilateral sphenopalatine ganglion block and trans-oral bilateral infraorbital nerve block.

GR [General anesthesia + regional block]

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • American Society of Anesthesiologists (ASA) physical status I-II
  • Scheduled for elective septo-rhinoplasty surgery

You may not qualify if:

  • Patients with hypertension or coronary artery disease,
  • Patients with renal, hepatic or cerebral insufficiency,
  • Patients with coagulopathy or receiving drugs influencing blood coagulation,
  • Patients with known sensitivity to any of the study drug

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain Shams University

Cairo, 11591, Egypt

Location

MeSH Terms

Interventions

Anesthesia, General

Intervention Hierarchy (Ancestors)

AnesthesiaAnesthesia and Analgesia

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assisstant Professor

Study Record Dates

First Submitted

December 11, 2018

First Posted

December 13, 2018

Study Start

November 28, 2018

Primary Completion

February 1, 2019

Study Completion

March 1, 2019

Last Updated

December 17, 2018

Record last verified: 2018-12

Locations